Company
Become an
Investor
We are opening our next growth chapter to private investors through a pre-listing funding round based on convertible notes.
Investment offering
- €2,500
- Bronze
- €5,000
- Silver
- €10,000
- Gold
- +€10,000
- Platinum
Invest in the future of on-site analysis
Traditional spectroscopy for complex liquids and particles is expensive, complex, and lab-bound. We make it portable, connected, and usable in challenging environments.
- IoT-connected — real-time results, anywhere
- 99% lower setup cost — no bulky lab equipment
- Patent protected — core IP secured
- Global traction — active in 20+ countries
- No specialist needed — simple, plug-and-play use
Our vision. Any lab, production line or field site can run advanced tests — no specialist and no multimillion-euro instrument. With your support we scale into life sciences, water quality, food, petrochemicals and defence.
The world is changing
Why now?
Traditional testing of food, fuel, oil and lubricants no longer fits requirements for mobility, dual use and performance.
As a European manufacturer we are positioned for a unique market within NATO as defence spending rises.
Customers want new technology without buying another scientific instrument.
The problem
Lab-bound testing is too slow, too expensive, and too far from the sample.
-
Time-consuming processes
Traditional lab testing takes days or weeks, delaying critical decisions.
-
Logistical nightmare
Samples travel to and from remote sites, with degradation and handling errors along the way.
-
High costs
GC, MS, FTIR, DLS and specialised staff drive operational cost.
-
Limited accessibility
Without point-of-need testing, teams cannot act on findings immediately.
The solution? A universal concept for liquid and particle analysis
Use our no-lab platform for physical, chemical and biological analysis of complex liquid samples.
Benefits
-
Rapid results
Nanotechnology takes testing from days to minutes.
-
Mobile integration
Portable devices bring lab-level accuracy to the field.
-
Cost efficiency
Less lab infrastructure and logistics, lower overall cost.
-
Real-time decisions
Immediate results support on-the-spot action.
Introducing
[No-lab]
No-lab is our next-generation platform for physical, chemical and biological analysis that eliminates the need for conventional lab infrastructure. By combining miniaturized photonic chips, optical simulations, and machine learning, users get instant, accurate results — anywhere, anytime, even without a lab.
Traditional lab analysis
- Benchtop instruments (HPLC, LC-MS, DLS etc.)
- Complicated chemical assays and pretreatment
- Trained technicians
- Long turnaround times
- Centralized setup
Next-gen no-lab analysis
- Embedded photonic chips for UV-Vis
- Intuitive tools, no training needed
- Instant results for default parameters or ML
- Decentralized, on-the-go measurement
- Low cost, scalable, plug-and-play
Trusted. Validated. Ready to scale.
-
KPMG Tech Innovator DK
Winner, 2022.
-
Research-backed IP
Own IP and licensed IP from DTU, backed by world-class research.
-
400+ investors
Including industry experts, research institutions, grant funding and private capital.
Target markets
Life sciences, water, food, petrochemicals and defence — the same platform, different samples.
-
Defence
On-site analysis where mobility and dual use matter.
-
Petrochemicals
Fuels, oils and lubricants without shipping every sample to a central lab.
-
Food
Quality checks closer to production.
-
Research
Lab-grade insight without a dedicated instrument for every method.
Customers & business model
We generate recurring and scalable revenue from:
-
Consumables
Proprietary cuvettes and other formats.
-
Hardware sales
Smart devices for lab and production use.
-
Software subscriptions
Connected data and analytics tools.
-
Partnerships
OEM and academic partnerships.
25% extra shares at conversion, or your money back with interest
We offer time-limited convertible loans. The agreement runs until the end of 2028. You can convert with a 25% discount into shares, or keep the loan as debt repaid at 3% p.a.*
Example: an investor contributing €1,000 can choose shares for €1,250 or repayment with interest.*
A free package of our patented testing consumables is included with your investment.
*See the terms and conditions for all details. This is not a public offering of shares.
Disclaimer
This offering of convertible loans by Alontia does not require a prospectus in accordance with Regulation (EU) 2017/1129, as the total offering is below EUR 8 million within a 12-month period.
Investments in convertible loans carry risks, including potential loss of capital. The investment is not covered by any guarantee scheme and is illiquid. Investors may not recover the full amount invested.
This is not a public offering of shares, but a private offering of convertible debt instruments. All potential investors are subject to approval by Alontia before investing.